Summary--calcium receptors: potential targets for novel treatments for skeletal disease.
Nemeth
E F
EF
NPS Pharmaceuticals, Inc., Toronto, Ontario, Canada. enemeth@npsp.com
D001842:Bone and Bones / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology*; D002118:Calcium / Q000378:metabolism*; D000069449:Cinacalcet; D006801:Humans; D006961:Hyperparathyroidism / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D009281:Naphthalenes / Q000494:pharmacology / Q000627:therapeutic use; D010024:Osteoporosis / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D010281:Parathyroid Hormone / Q000037:antagonists & inhibitors / Q000378:metabolism; D044169:Receptors, Calcium-Sensing / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*
D009281:Naphthalenes; D010281:Parathyroid Hormone; D044169:Receptors, Calcium-Sensing; D002118:Calcium; D000069449:Cinacalcet